138 related articles for article (PubMed ID: 12608943)
41. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
Palomba S; Orio F; Manguso F; Falbo A; Russo T; Tolino A; Tauchmanovà L; Colao A; Doldo P; Mastrantonio P; Zullo F
Osteoporos Int; 2005 Sep; 16(9):1141-9. PubMed ID: 15928801
[TBL] [Abstract][Full Text] [Related]
42. Association Between Polymorphisms of VDR, COL1A1, and LCT genes and bone mineral density in Belarusian women with severe postmenopausal osteoporosis.
Marozik P; Mosse I; Alekna V; Rudenko E; Tamulaitienė M; Ramanau H; Strazdienė V; Samokhovec V; Ameliyanovich M; Byshnev N; Gonchar A; Kundas L; Zhur K
Medicina (Kaunas); 2013; 49(4):177-84. PubMed ID: 23985982
[TBL] [Abstract][Full Text] [Related]
43. Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women.
Pérez A; Ulla M; García B; Lavezzo M; Elías E; Binci M; Rivoira M; Centeno V; Alisio A; Tolosa de Talamoni N
J Bone Miner Metab; 2008; 26(4):358-65. PubMed ID: 18600402
[TBL] [Abstract][Full Text] [Related]
44. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
45. The BsmI vitamin D receptor gene polymorphism in Israeli populations and in perimenopausal and osteoporotic Ashkenazi women.
Pollak RD; Blumenfeld A; Bejarano-Achache I; Idelson M; Celinke Hochner D
Am J Nephrol; 2001; 21(3):185-8. PubMed ID: 11423686
[TBL] [Abstract][Full Text] [Related]
46. [The association between vitamin D receptor gene polymorphisms, bone mineral density and osteocalcin in Chinese women].
Zhao J; Zhou X; Meng X; Liu G; Xing X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):252-6. PubMed ID: 10453562
[TBL] [Abstract][Full Text] [Related]
47. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms.
Ferrari S; Rizzoli R; Manen D; Slosman D; Bonjour JP
J Bone Miner Res; 1998 Jun; 13(6):925-30. PubMed ID: 9626623
[TBL] [Abstract][Full Text] [Related]
48. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
49. Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
Boroń D; Kamiński A; Kotrych D; Bogacz A; Uzar I; Mrozikiewicz PM; Czerny B
Osteoporos Int; 2015 Mar; 26(3):1045-52. PubMed ID: 25407264
[TBL] [Abstract][Full Text] [Related]
50. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women.
Durusu Tanriover M; Bora Tatar G; Uluturk TD; Dayangac Erden D; Tanriover A; Kilicarslan A; Oz SG; Erdem Yurter H; Sozen T; Sain Guven G
Clin Rheumatol; 2010 Nov; 29(11):1285-93. PubMed ID: 20697762
[TBL] [Abstract][Full Text] [Related]
52. Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.
Ishijima M; Sakamoto Y; Yamanaka M; Tokita A; Kitahara K; Kaneko H; Kurosawa H
Calcif Tissue Int; 2009 Nov; 85(5):398-404. PubMed ID: 19795092
[TBL] [Abstract][Full Text] [Related]
53. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype.
Graafmans WC; Lips P; Ooms ME; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 1997 Aug; 12(8):1241-5. PubMed ID: 9258754
[TBL] [Abstract][Full Text] [Related]
54. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
55. Does the
Wawrzyniak A; Skrzypczak-Zielińska M; Michalak M; Kaczmarek-Ryś M; Ratajczak AE; Rychter AM; Skoracka K; Marcinkowska M; Słomski R; Dobrowolska A; Krela-Kaźmierczak I
Front Endocrinol (Lausanne); 2022; 13():1063762. PubMed ID: 36714573
[TBL] [Abstract][Full Text] [Related]
56. Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis.
Palomba S; Orio F; Colao A; di Carlo C; Sena T; Lombardi G; Zullo F; Mastrantonio P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1502-8. PubMed ID: 11932272
[TBL] [Abstract][Full Text] [Related]
57. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women.
Riggs BL; Nguyen TV; Melton LJ; Morrison NA; O'Fallon WM; Kelly PJ; Egan KS; Sambrook PN; Muhs JM; Eisman JA
J Bone Miner Res; 1995 Jun; 10(6):991-6. PubMed ID: 7572325
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms of vitamin D receptor gene and its association with bone mineral density and osteocalcin in Chinese.
Zhao J; Zhou X; Meng X; Liu G; Xing X; Liu H; Xu L
Chin Med J (Engl); 1997 May; 110(5):366-71. PubMed ID: 9594305
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D receptor genotype and bone mineral density in Caucasian children with congenital hypothyroidism.
Léger J; Tourrel C; Ruiz JC; Czernichow P; Garabedian M
J Pediatr Endocrinol Metab; 2000 Jun; 13(6):599-603. PubMed ID: 10905383
[TBL] [Abstract][Full Text] [Related]
60. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men.
Braga V; Sangalli A; Malerba G; Mottes M; Mirandola S; Gatti D; Rossini M; Zamboni M; Adami S
Calcif Tissue Int; 2002 Jun; 70(6):457-62. PubMed ID: 12016463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
